REGIONAL ANALGESIA TECHNIQUES FOR EFFECTIVE RECOVERY TO CORONARY ARTERY BYPASS SURGERIES: A RETROSPECTİVE STUDY IN A SINGLE CENTER EXPERIENCE

Sponsor
V.K.V. American Hospital, Istanbul (Other)
Overall Status
Completed
CT.gov ID
NCT05282303
Collaborator
(none)
221
1
6.4
34.7

Study Details

Study Description

Brief Summary

Background Pain after cardiac surgery is both multifocal and multifactorial. Sternotomy, sternal retraction, internal mammary dissection, posterior rib dislocation or fracture, possible brachial plexus injury, and mediastinal and pleural drains contribute to pain experienced in the immediate postoperative period. Ineffective pain management can cause systemic and pulmonary complications and significant cardiac consequences.

Methods This study was conducted to compare the effectiveness of regional anesthesia techniques for perioperative pain management in cardiac surgery patients at our clinic. The effects of analgesic methods, in terms of contributing to recovery, have been examined.

Condition or Disease Intervention/Treatment Phase
  • Procedure: CABG operation

Detailed Description

This study was approved by the Koç University Clinical Research Ethics Committee (2021.464.IRB1.131); patients who underwent coronary artery bypass grafting (CABG) surgery at the VKV American Hospital between January 2015 and May 2020 were reviewed retrospectively. Patients with a history of cerebrovascular events, scheduled carotid surgery, or emergency CABG surgery were excluded from the study. Demographic data from the preoperative evaluation forms and operation types from the surgery reports were recorded. Intraoperative anesthesia follow-up forms were assessed if regional anesthesia was used, and the type and extent of opioids during the operation were examined. The postoperative transfer forms were examined to the cardiovascular intensive care unit (CICU), intensive care follow-up forms, and service ward record follow-up forms. Pain scores (NRS) during rest and coughing, vital signs, mobilization, and the start of respiratory exercises were recorded for postoperative respiratory complications.

Study Design

Study Type:
Observational
Actual Enrollment :
221 participants
Observational Model:
Case-Only
Time Perspective:
Retrospective
Official Title:
REGIONAL ANALGESIA TECHNIQUES FOR EFFECTIVE RECOVERY TO CORONARY ARTERY BYPASS SURGERIES: A RETROSPECTİVE STUDY IN A SINGLE CENTER EXPERIENCE
Actual Study Start Date :
Jul 10, 2020
Actual Primary Completion Date :
Jan 1, 2021
Actual Study Completion Date :
Jan 20, 2021

Arms and Interventions

Arm Intervention/Treatment
DIESPB

Dual injection of erector spinae plane block

Procedure: CABG operation
Efficacy of regional analgesia techniques in coronary artery bypass operations

TPVB

Thoracic paravertebral block

Procedure: CABG operation
Efficacy of regional analgesia techniques in coronary artery bypass operations

SAB

Serratus anterior plane block

Procedure: CABG operation
Efficacy of regional analgesia techniques in coronary artery bypass operations

PIB

Parasternal ıntercostal block

Procedure: CABG operation
Efficacy of regional analgesia techniques in coronary artery bypass operations

Outcome Measures

Primary Outcome Measures

  1. Postoperative analgesia [0 - 24 hours]

    NRS score

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Who underwent coronary artery bypass grafting (CABG) surgery at the VKV American Hospital between January 2015 and May 2020 were reviewed retrospectively
Exclusion Criteria:
  • History of cerebrovascular event

  • History of Alzheimer's and dementia

  • Inadequate cognitive functions

  • History of chronic pain

  • Long-term opioid therapy

Contacts and Locations

Locations

Site City State Country Postal Code
1 American Hospital Istanbul Turkey 34365

Sponsors and Collaborators

  • V.K.V. American Hospital, Istanbul

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Sami Kaan Coşarcan, MD, V.K.V. American Hospital, Istanbul
ClinicalTrials.gov Identifier:
NCT05282303
Other Study ID Numbers:
  • Cosarcan3
First Posted:
Mar 16, 2022
Last Update Posted:
Mar 16, 2022
Last Verified:
Mar 1, 2022
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Mar 16, 2022